Capecitabine, DNA/RNA Synthesis Inhibitor

Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.

Cancer & Cancer Drug

Cancers, Free Full-Text

Capecitabine

Chemotherapy

Oxaliplatin, CAS#:63121-00-6

DNA Synthesis Inhibitors- Definition, Examples, Inhibition, Resistance

Cell Cycle Inhibitor Immunology Reagents - Creative Diagnostics

Gupta Cancer Part 2 Flashcards

Capecitabine-d11, Stable Isotope

Capecitabine, C15H22FN3O6

Capecitabine induces hand-foot syndrome through elevated thymidine phosphorylase-mediated locoregional toxicity and GSDME-driven pyroptosis that can be relieved by tipiracil

Chemotherapy and Transplantation: The Role of Immunosuppression in Malignancy and a Review of Antineoplastic Agents in Solid Organ Transplant Recipients - American Journal of Transplantation